-
)
Lukas Wagener
Tracking biomarker evolution during tumor progression in metastatic breast cancer within CATCH: Clinical impact of longitudinal molecular profiling and repeated MTBs
Department I of Internal Medicine, Cologne National Center for Tumor Diseases, NCT Heidelberg
-
)
Luís António Marques da Costa
Beacon reveals conserved response and therapy-specific non-response across a multi-residue immune-state signature in metastatic breast cancer
Director, Group Leader
Oncology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. Translational Oncology, Gulbenkian Institute for Molecular Medicine (GIMM) / iMM, Lisbon, Portugal -
)
Lisa Julian
Quantitative Single-lumen Human Brain Organoid Platform for Precision Variant Interpretation
Associate Professor,
Department of Biochemistry and Molecular Biology, Simon Fraser University, Burnaby, BC, Canada
-
)
Amarin Wongariyapek
Harnessing failed cytokinesis to enhance oncolytic herpes virus therapy
PhD student,
The Institute of Cancer Research, London -
)
Olga Piskareva
Targeting GPC2-positive tumours with mRNA vaccine -
Sarah Charnaud
From innovation to equity: mapping global gaps in precision medicine research using WHO Global Observatory for Health R&D data
-
)
Daniell Wise
Mechanism-Driven Colorectal Cancer Detection through Hologenomic Integration of Rectal Mucus Multiomics
)